Michael A. Hollingsworth
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
BiochemistryWebsite:
https://www.unmc.edu/eppley/about/faculty/hollingsworth.htmlGoogle:
"Michael Hollingsworth"Bio:
https://books.google.com/books?id=pJYvAQAAIAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentorDonald L. Evans | grad student | 1982 | Wake Forest School of Medicine | |
(Characterization of spleen cell proliferative responses, resistance to syngeneic tumor growth, and immunoregulatory activity in aging New Zealand black rats.) |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mundry CS, Triplett AA, Shah OS, et al. (2024) Single-cell RNA-sequencing of human spleens reveals an IDO-1 tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals. Cancer Letters. 607: 217321 |
Mullen NJ, Shukla SK, Thakur R, et al. (2024) DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 12 |
Kotwal A, Vance K, Hajric K, et al. (2024) Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association |
Zheng D, Grandgenett PM, Zhang Q, et al. (2024) radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer. Scientific Reports. 14: 12316 |
Murthy D, Attri KS, Shukla SK, et al. (2024) Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nature Cell Biology |
Murthy D, Attri KS, Suresh V, et al. (2024) The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proceedings of the National Academy of Sciences of the United States of America. 121: e2315509121 |
Mack KN, Samuels ZV, Carter LM, et al. (2024) Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
Murthy D, Attri KS, Shukla SK, et al. (2024) Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nature Cell Biology |
Aguilar EN, Sagar S, Murray BR, et al. (2024) Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular Cancer Therapeutics |
Dailey KM, Small JM, Pullan JE, et al. (2023) An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183 |